Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease ; volume:15 ; number:1 ; day:15 ; month:2 ; year:2018 ; pages:1-11 ; date:12.2018
Journal of neuroinflammation ; 15, Heft 1 (15.2.2018), 1-11, 12.2018
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Casali, Brad T.
- Contributor
-
Reed-Geaghan, Erin G.
Landreth, Gary E.
SpringerLink (Online service)
- DOI
-
10.1186/s12974-018-1091-y
- URN
-
urn:nbn:de:1111-201804082548
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Casali, Brad T.
- Reed-Geaghan, Erin G.
- Landreth, Gary E.
- SpringerLink (Online service)
Other Objects (12)
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease